The better teams can see who and where is affected in an outbreak, the smaller the response they can safely choose.
Tim Jones
Winter is Coming
Winter is coming, and with it the yearly clash between infection control and patient flow. Norovirus and respiratory viruses arrive just as demand for beds peaks, and the measures that contain them, such as isolating patients and closing bays, also take beds out of use.
Infection Prevention and Control (IPC) teams need affected patients separated. Bed management teams need beds open. Both are trying to keep patients safe, and both usually have to decide quickly, with an incomplete picture of who has been exposed and where.
Our central point is that the better teams can see who and where is affected, the smaller the response they can safely choose. This article sets out what the evidence says about closures, what UK guidance asks for and how better information can help.
Outbreaks Cost Beds as Well as Cases
Every closure decision is also a capacity decision. Last winter showed how much norovirus alone can take out of England's hospitals (NHS England, 2026; UKHSA, 2026).
Isolation has a cost too. During a scabies outbreak on one paediatric haematology and oncology unit, single-room isolation halved the unit's bed capacity (Uygun et al., 2025). Decisions that protect patients from infection can quickly affect the beds available for everyone else.
The Evidence for Closing Wards Is Thin
Ward closure is a standard response to outbreaks, yet it has never been properly tested. A systematic review of 97 studies found none that compared it with other measures in a controlled way, and concluded that teams are left balancing competing risks case by case (Wong et al., 2015).
We looked for newer studies comparing bay and ward closures and found none. The studies here, published between 2012 and 2016, are still the best evidence available, and the 2023 UK guidelines on norovirus outbreaks describe the evidence behind current practice as poor (Chadwick et al., 2023).
What evidence there is suggests speed matters. National data on hospital norovirus outbreaks in England from 2009 to 2012 found that closing a bay or ward within three days of the first case was associated with shorter outbreaks, less disruption and fewer patients affected than closing later (Harris et al., 2014). Outbreaks where nothing was closed did about as well, so closure alone may not explain the difference, and the authors say the results are hard to interpret.
Closure also has a cost. A UK cost-effectiveness analysis found ward closure reduced new outbreaks by between 6% and 56%, depending on how well it worked, and was most likely to be worth its cost on high-throughput wards (Sadique et al., 2016). This suggests closure is most valuable when it's targeted.
Smaller Closures Can Work When the Extent Is Clear
Closing a whole ward isn't the only option. One UK hospital started cohorting symptomatic norovirus patients in bays early, then moved them as beds became free so areas could be cleaned and reopened sooner (Haill et al., 2012).
The approach depends on knowing which patients and places are affected. When that picture is unclear, closing the ward can feel like the only safe choice.
UK Guidance Relies on Risk Assessment
Because the evidence is thin, the 2023 UK guidelines lean on risk assessment rather than fixed rules. Their practical points are still useful (Chadwick et al., 2023).
Start control measures as soon as an outbreak is suspected, without waiting for results.
Keep reassessing whether an affected area needs to close quickly.
Avoid moving patients into or out of affected areas.
Confirm cases with PCR, and don't rely on a rapid antigen test to rule norovirus out.
Keep measures in place until 72 hours after the last case's symptoms stop.
Where the risk is high, consider small layout changes such as bay doors or partitions.
Flu follows similar logic. A 2025 review of post-COVID hospital practice suggests treating two linked, laboratory-confirmed cases on the same ward within 72 hours as an outbreak, and cohorting quickly with dedicated staff (Huang et al., 2025).
Each of these steps relies on knowing quickly who is affected and where they've been.
Making the Extent of an Outbreak Easier to See
NEX is intended to give IPC teams those answers sooner. Our Outbreak Intelligence work automates much of the contact tracing that teams currently do by hand. It brings microbiology results, patient movements and ward locations together, so teams can see connected cases, shared locations and possible exposures in one place.
NEX is a UKCA-marked Class I medical device in Great Britain, intended to support clinical decision-making (NEX Health Intelligence, 2026). A recorded overlap is evidence of a possible exposure, and it doesn't replace typing, environmental sampling or clinical review. NEX does not diagnose infection or confirm transmission, and decisions stay with the teams who know their hospital.
Our aim this winter is to make the extent of an outbreak easier to see, so the response can be as large as it needs to be and no larger.
